COURTNEY FERNANDEZ: Open Payments
NPI 1063183978 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 111 payments from 17 companies in 2025. Trend: 2023 $1,590 · 2024 $1,561 · 2025 $1,611
Food & beverage: $1,611
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $249 |
| ABBVIE INC. | 24 | $239 |
| AstraZeneca Pharmaceuticals LP | 9 | $231 |
| PFIZER INC. | 15 | $215 |
| Lilly USA, LLC | 12 | $214 |
| GlaxoSmithKline, LLC. | 14 | $156 |
| Biogen, Inc. | 3 | $61 |
| Abbott Laboratories | 3 | $53 |
| Astellas Pharma US Inc | 2 | $36 |
| Amgen Inc. | 2 | $30 |
Products named: MOUNJARO, NURTEC ODT, BREZTRI, TRELEGY ELLIPTA, QULIPTA, VRAYLAR, Wegovy, JARDIANCE.
Industry payments across TX — which companies pay providers there.
